Access the full text.
Sign up today, get DeepDyve free for 14 days.
Z. Li, J. Xiao, X. Wu, W. Li, Z. Yang, J. Xie, L. Xu, X. Cai, Z. Lin, W. Guo, J. Luo, M. Liu (2012)Plumbagin inhibits breast tumor bone metastasis and osteolysis by modulating the tumor-bone microenvironment.
Current molecular medicine, 12 8
Shadan Ali, Aamir Ahmad, Sanjeev Banerjee, S. Padhye, Kristin Dominiak, J. Schaffert, Zhiwei Wang, P. Philip, F. Sarkar (2010)Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDF.
Cancer research, 70 9
L. Sempere, M. Christensen, A. Silahtaroglu, M. Bak, C. Heath, G. Schwartz, W. Wells, S. Kauppinen, C. Cole (2007)Altered MicroRNA expression confined to specific epithelial cell subpopulations in breast cancer.
Cancer research, 67 24
Ritu Kulshreshtha, M. Ferracin, Sylwia Wojcik, R. Garzon, H. Alder, Francisco Agosto-Perez, R. Davuluri, Chang-gong Liu, C. Croce, M. Negrini, G. Calin, M. Ivan (2006)A MicroRNA Signature of Hypoxia
Molecular and Cellular Biology, 27
Hua Zhao, Jie Shen, Leonardo Medico, Dan Wang, C. Ambrosone, Song Liu (2010)A Pilot Study of Circulating miRNAs as Potential Biomarkers of Early Stage Breast Cancer
PLoS ONE, 5
C. DeSantis, Jiemin Ma, Leah Bryan, A. Jemal (2014)Breast cancer statistics, 2013
CA: A Cancer Journal for Clinicians, 64
Ashhar Ali, Aamir Ahmad, Shadan Ali, B. Bao, P. Philip, F. Sarkar (2013)The role of cancer stem cells and miRNAs in defining the complexities of brain metastasis
Journal of Cellular Physiology, 228
M. Czyzyk-Krzeska, X. Zhang (2014)MiR-155 at the heart of oncogenic pathways
Aaron Gruver, B. Portier, R. Tubbs (2011)Molecular pathology of breast cancer: the journey from traditional practice toward embracing the complexity of a molecular classification.
Archives of pathology & laboratory medicine, 135 5
Haiyan Si, Xiaoming Sun, Ying-jian Chen, Yuan Cao, Shimin Chen, Huanchun Wang, Chengjin Hu (2012)Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer
Journal of Cancer Research and Clinical Oncology, 139
Li Ma, J. Teruya-Feldstein, R. Weinberg (2007)Tumour invasion and metastasis initiated by microRNA-10b in breast cancer
Christine Esau, Scott Davis, S. Murray, Xing Yu, S. Pandey, Michael Pear, L. Watts, S. Booten, M. Graham, R. Mckay, Amuthakannan Subramaniam, S. Propp, B. Lollo, S. Freier, C. Bennett, S. Bhanot, B. Monia (2006)miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting.
Cell metabolism, 3 2
A. Shehzad, Salma Khan, Young Lee (2012)Curcumin molecular targets in obesity and obesity-related cancers.
Future oncology, 8 2
An-Chin Cheng, Mei-Ling Tsai, Chi-Mei Liu, Ming-Fen Lee, K. Nagabhushanam, C. Ho, M. Pan (2010)Garcinol inhibits cell growth in hepatocellular carcinoma Hep3B cells through induction of ROS-dependent apoptosis.
Food & function, 1 3
L. Masuelli, M. Benvenuto, M. Fantini, L. Marzocchella, P. Sacchetti, Enrica Stefano, I. Tresoldi, V. Izzi, R. Bernardini, C. Palumbo, M. Mattei, F. Lista, F. Galvano, A. Modesti, R. Bei (2013)Curcumin induces apoptosis in breast cancer cell lines and delays the growth of mammary tumors in neu transgenic mice.
Journal of biological regulators and homeostatic agents, 27 1
X. Li, Suraya Roslan, Cameron Johnstone, Cameron Johnstone, Josephine Wright, Josephine Wright, C. Bracken, C. Bracken, M. Anderson, A. Bert, L. Selth, Robin Anderson, Robin Anderson, G. Goodall, G. Goodall, P. Gregory, P. Gregory, Y. Khew-Goodall, Y. Khew-Goodall (2014)MiR-200 can repress breast cancer metastasis through ZEB1-independent but moesin-dependent pathways
K. Manu, M. Shanmugam, P. Rajendran, Feng Li, Lalitha Ramachandran, Hui Hay, Radhamani Kannaiyan, S. Swamy, S. Vali, S. Kapoor, B. Ramesh, P. Bist, E. Koay, L. Lim, K. Ahn, A. Kumar, G. Sethi (2011)Plumbagin inhibits invasion and migration of breast and gastric cancer cells by downregulating the expression of chemokine receptor CXCR4
Molecular Cancer, 10
S. Kanwar, Yingjie Yu, Jyoti Nautiyal, B. Patel, S. Padhye, F. Sarkar, A. Majumdar (2011)Difluorinated-Curcumin (CDF): A Novel Curcumin Analog is a Potent Inhibitor of Colon Cancer Stem-Like Cells
Pharmaceutical Research, 28
Shadan Ali, K. Almhanna, Wei Chen, P. Philip, F. Sarkar (2010)Differentially expressed miRNAs in the plasma may provide a molecular signature for aggressive pancreatic cancer.
American journal of translational research, 3 1
N. Yanaihara, N. Caplen, E. Bowman, M. Seike, K. Kumamoto, M. Yi, R. Stephens, A. Okamoto, J. Yokota, Tadao Tanaka, G. Calin, Chang-gong Liu, C. Croce, C. Harris (2006)Unique microRNA molecular profiles in lung cancer diagnosis and prognosis.
Cancer cell, 9 3
R. Piva, D. Spandidos, R. Gambari (2013)From microRNA functions to microRNA therapeutics: Novel targets and novel drugs in breast cancer research and treatment
International Journal of Oncology, 43
Aamir Ahmad, Sanila Sarkar, Bassam Bitar, Shadan Ali, A. Aboukameel, S. Sethi, Yiwei Li, B. Bao, D. Kong, Sanjeev Banerjee, S. Padhye, F. Sarkar (2012)Garcinol Regulates EMT and Wnt Signaling Pathways In Vitro and In Vivo, Leading to Anticancer Activity against Breast Cancer Cells
Molecular Cancer Therapeutics, 11
Liqiang Qi, J. Bart, L. Tan, I. Platteel, T. Sluis, S. Huitema, G. Harms, L. Fu, H. Hollema, A. Berg (2009)Expression of miR-21 and its targets (PTEN, PDCD4, TM1) in flat epithelial atypia of the breast in relation to ductal carcinoma in situ and invasive carcinoma
BMC Cancer, 9
Yu Liang, Dana Ridzon, Linda Wong, Caifu Chen (2007)Characterization of microRNA expression profiles in normal human tissues
BMC Genomics, 8
Jingjing Liu, Q. Mao, Yan Liu, Xiaomeng Hao, S. Zhang, Jin Zhang (2013)Analysis of miR-205 and miR-155 expression in the blood of breast cancer patients.
Chinese journal of cancer research = Chung-kuo yen cheng yen chiu, 25 1
M. Iorio, M. Ferracin, Chang-gong Liu, A. Veronese, R. Spizzo, S. Sabbioni, E. Magri, M. Pedriali, M. Fabbri, M. Campiglio, S. Ménard, J. Palazzo, A. Rosenberg, P. Musiani, S. Volinia, I. Nenci, G. Calin, P. Querzoli, M. Negrini, C. Croce (2005)MicroRNA gene expression deregulation in human breast cancer.
Cancer research, 65 16
Sipahi Ml, Shuomin Zhu, Hailong Wu, Zhaohui Lu, Fangting Wu, Y. Mo (2007)miR-21-mediated tumor growth
H. Tan, W. Qian, Lian‐zhou Chen, Xiao‐hui Huang, Jin-song Chen, Xinhui Fu, Liang-qi Cao, Xi-ling Chen, Li Wen, Long‐juan Zhang (2010)MicroRNA-9 reduces cell invasion and E-cadherin secretion in SK-Hep-1 cell
Medical Oncology, 27
Supachai Yodkeeree, C. Ampasavate, Bokyung Sung, B. Aggarwal, P. Limtrakul (2010)Demethoxycurcumin suppresses migration and invasion of MDA-MB-231 human breast cancer cell line.
European journal of pharmacology, 627 1-3
C. Perou, T. Sørlie, M. Eisen, M. Rijn, S. Jeffrey, Christian Rees, J. Pollack, D. Ross, H. Johnsen, L. Akslen, Ø. Fluge, Alexander Pergamenschikov, Cheryl Williams, Shirley Zhu, P. Lønning, A. Børresen-Dale, P. Brown, D. Botstein (2000)Molecular portraits of human breast tumours
S. Sun, Hsiu-Chen Huang, Cheng Huang, Jen-kun Lin (2012)Cycle arrest and apoptosis in MDA-MB-231/Her2 cells induced by curcumin.
European journal of pharmacology, 690 1-3
Aamir Ahmad, Zhiwei Wang, R. Ali, Ma'in Maitah, D. Kong, Sanjeev Banerjee, S. Padhye, F. Sarkar (2010)Apoptosis‐inducing effect of garcinol is mediated by NF‐κB signaling in breast cancer cells
Journal of Cellular Biochemistry, 109
Yiwei Li, T. Vandenboom, D. Kong, Zhiwei Wang, Shadan Ali, P. Philip, F. Sarkar (2009)Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells.
Cancer research, 69 16
P. Tang, K. Skinner, D. Hicks (2009)Molecular Classification of Breast Carcinomas by Immunohistochemical Analysis: Are We Ready?
Diagnostic Molecular Pathology, 18
Liang Chen, Youhuai Li, Yebo Fu, Jin Peng, Meng-Hsuan Mo, M. Stamatakos, C. Teal, R. Brem, A. Stojadinovic, M. Grinkemeyer, T. McCaffrey, Y. Man, S. Fu (2013)Role of Deregulated microRNAs in Breast Cancer Progression Using FFPE Tissue
PLoS ONE, 8
Aamir Ahmad, A. Aboukameel, D. Kong, Zhiwei Wang, S. Sethi, Wei Chen, F. Sarkar, A. Raz (2011)Phosphoglucose isomerase/autocrine motility factor mediates epithelial-mesenchymal transition regulated by miR-200 in breast cancer cells.
Cancer research, 71 9
T. Gall, A. Frampton, J. Krell, L. Castellano, J. Stebbing, L. Jiao (2013)Blood-based miRNAs as noninvasive diagnostic and surrogative biomarkers in colorectal cancer
Expert Review of Molecular Diagnostics, 13
M. Bloomston, W. Frankel, F. Petrocca, S. Volinia, H. Alder, J. Hagan, Chang-gong Liu, Darshna Bhatt, C. Taccioli, C. Croce (2007)MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis.
JAMA, 297 17
Aamir Ahmad, Zhiwei Wang, Christine Wojewoda, R. Ali, D. Kong, Ma'in Maitah, Sanjeev Banerjee, B. Bao, S. Padhye, F. Sarkar (2011)Garcinol-induced apoptosis in prostate and pancreatic cancer cells is mediated by NF- kappaB signaling.
Frontiers in bioscience, 3
W. Kong, Lili He, M. Coppola, Jian-ping Guo, N. Esposito, D. Coppola, J. Cheng (2010)MicroRNA-155 Regulates Cell Survival, Growth, and Chemosensitivity by Targeting FOXO3a in Breast Cancer*
The Journal of Biological Chemistry, 285
D. Kong, Sanjeev Banerjee, Aamir Ahmad, Yiwei Li, Zhiwei Wang, S. Sethi, F. Sarkar (2010)Epithelial to Mesenchymal Transition Is Mechanistically Linked with Stem Cell Signatures in Prostate Cancer Cells
PLoS ONE, 5
S. Sethi, Shadan Ali, D. Kong, P. Philip, F. Sarkar (2013)Clinical implication of microRNAs in molecular pathology.
Clinics in laboratory medicine, 33 4
J. Chen, X. Wang (2014)MicroRNA-21 in breast cancer: diagnostic and prognostic potential
Clinical and Translational Oncology, 16
Yat-Yuen Lim, Josephine Wright, J. Attema, P. Gregory, A. Bert, Eric Smith, Daniel Thomas, Angel Lopez, P. Drew, Y. Khew-Goodall, G. Goodall (2013)Epigenetic modulation of the miR-200 family is associated with transition to a breast cancer stem-cell-like state
Journal of Cell Science, 126
M. Nugent, Nicola Miller, Michael Kerin (2012)Circulating miR‐34a levels are reduced in colorectal cancer
Journal of Surgical Oncology, 106
F. Orso, F. Balzac, M. Marino, A. Lembo, S. Retta, D. Taverna (2013)miR-21 coordinates tumor growth and modulates KRIT1 levels
Biochemical and Biophysical Research Communications, 438
Xinsheng Peng, W. Guo, Tiejian Liu, Xi Wang, Xiang'an Tu, Da-fu Xiong, Song Chen, Yingrong Lai, Hong Du, Guang-fu Chen, Guan-jian Liu, Yubo Tang, Shuai Huang, X. Zou (2011)Identification of miRs-143 and -145 that Is Associated with Bone Metastasis of Prostate Cancer and Involved in the Regulation of EMT
PLoS ONE, 6
Shu-rong Zheng, G. Guo, Q. Zhai, Zhang-yong Zou, Wei Zhang (2013)Effects of miR-155 antisense oligonucleotide on breast carcinoma cell line MDA-MB-157 and implanted tumors.
Asian Pacific journal of cancer prevention : APJCP, 14 4
B. Bao, Shadan Ali, D. Kong, Sanila Sarkar, Zhiwei Wang, Sanjeev Banerjee, A. Aboukameel, S. Padhye, P. Philip, F. Sarkar (2011)Anti-Tumor Activity of a Novel Compound-CDF Is Mediated by Regulating miR-21, miR-200, and PTEN in Pancreatic Cancer
PLoS ONE, 6
Xun Guo, Yuehan Wu, R. Hartley (2009)MicroRNA-125a represses cell growth by targeting HuR in breast cancer
RNA Biology, 6
F. Gottardo, Chang-gong Liu, M. Ferracin, G. Calin, M. Fassan, P. Bassi, C. Sevignani, D. Byrne, M. Negrini, F. Pagano, L. Gomella, C. Croce, R. Baffa (2007)Micro-RNA profiling in kidney and bladder cancers.
Urologic oncology, 25 5
G. Scott, A. Goga, D. Bhaumik, C. Berger, C. Sullivan, C. Benz (2007)Coordinate Suppression of ERBB2 and ERBB3 by Enforced Expression of Micro-RNA miR-125a or miR-125b*
Journal of Biological Chemistry, 282
Sun-Mi Park, A. Gaur, E. Lengyel, M. Peter (2008)The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2.
Genes & development, 22 7
Janaiah Kota, R. Chivukula, Kathryn O’Donnell, E. Wentzel, C. Montgomery, Hun-Way Hwang, Tsung Chang, P. Vivekanandan, M. Torbenson, K. Clark, K. Clark, Jerry Mendell, Jerry Mendell, J. Mendell (2009)Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer Model
Ching‐Shyang Chen, Chia-Hwa Lee, Chang-Da Hsieh, Chi-Tang Ho, M. Pan, Ching-Shui Huang, S. Tu, Ying-Jan Wang, Li‐Ching Chen, Yu-Jia Chang, P. Wei, Yi-yuan Yang, C. Wu, Y. Ho (2010)Nicotine-induced human breast cancer cell proliferation attenuated by garcinol through down-regulation of the nicotinic receptor and cyclin D3 proteins
Breast Cancer Research and Treatment, 125
Jiaoli Guo, Wenping Li, Hongliu Shi, Xinhua Xie, Laisheng Li, Hailin Tang, Minqing Wu, Y. Kong, Lu Yang, Jie Gao, Peng Liu, Weidong Wei, Xiaoming Xie (2013)Synergistic effects of curcumin with emodin against the proliferation and invasion of breast cancer cells through upregulation of miR-34a
Molecular and Cellular Biochemistry, 382
S. Nana-Sinkam, C. Croce (2013)Clinical Applications for microRNAs in Cancer
Clinical Pharmacology & Therapeutics, 93
Ingrid Hedenfalk, Ingrid Hedenfalk, Dave Duggan, Yidong Chen, M. Radmacher, M. Bittner, R. Simon, P. Meltzer, B. Gusterson, M. Esteller, M. Raffeld, Z. Yakhini, A. Ben-Dor, E. Dougherty, J. Kononen, L. Bubendorf, Wilfrid Fehrle, S. Pittaluga, Sofia Gruvberger, N. Loman, O. Johannsson, Hampus Olsson, B. Wilfond, G. Sauter, O. Kallioniemi, Å. Borg, J. Trent (2001)Gene-expression profiles in hereditary breast cancer.
The New England journal of medicine, 344 8
A. Feber, L. Xi, J. Luketich, A. Pennathur, R. Landreneau, Maoxin Wu, S. Swanson, T. Godfrey, V. Litle (2008)MicroRNA expression profiles of esophageal cancer.
The Journal of thoracic and cardiovascular surgery, 135 2
Jiu-xu Bai, Bo Yan, Zhi-ning Zhao, Xiao Xiao, Wei-wei Qin, Rui Zhang, L. Jia, Yan-ling Meng, Bo-Quan Jin, D. Fan, Tao Wang, A. Yang (2013)Tamoxifen represses miR-200 microRNAs and promotes epithelial-to-mesenchymal transition by up-regulating c-Myc in endometrial carcinoma cell lines.
Endocrinology, 154 2
Elizabeth O'Day, A. Lal (2010)MicroRNAs and their target gene networks in breast cancer
Breast Cancer Research : BCR, 12
S. Ciafrè, S. Galardi, A. Mangiola, M. Ferracin, Chang-gong Liu, G. Sabatino, M. Negrini, G. Maira, C. Croce, M. Farace (2005)Extensive modulation of a set of microRNAs in primary glioblastoma.
Biochemical and biophysical research communications, 334 4
M. Ferracin, P. Querzoli, G. Calin, M. Negrini (2011)MicroRNAs: toward the clinic for breast cancer patients.
Seminars in oncology, 38 6
T. Ka, Ratheeshkumar T., Rojini G., Sivakumar K.C., R. Nair, S. G, A. Banerji, Veena Somasundaram, P. Srinivas (2013)Structure activity relationship of plumbagin in BRCA1 related cancer cells
Molecular Carcinogenesis, 52
Guohong Hu, Qifeng Yang, Xiangfeng Cui, Gang Yue, Marco Azaro, Hui-Yun Wang, Honghua Li (2008)A highly sensitive and specific system for large-scale gene expression profiling
BMC Genomics, 9
Xiu-juan Li, M. Ji, Shanliang Zhong, Quanbin Zha, Jin-jin Xu, Jian-hua Zhao, Jin-hai Tang (2012)MicroRNA-34a modulates chemosensitivity of breast cancer cells to adriamycin by targeting Notch1.
Archives of medical research, 43 7
Takahiro Ichimi, H. Enokida, Y. Okuno, Ryo Kunimoto, T. Chiyomaru, K. Kawamoto, K. Kawahara, Kazuki Toki, Kazumori Kawakami, K. Nishiyama, G. Tsujimoto, M. Nakagawa, N. Seki (2009)Identification of novel microRNA targets based on microRNA signatures in bladder cancer
International Journal of Cancer, 125
A. Biragyn, M. Bodogai, P. Olkhanud, Sinan Denny-Brown, Nitin Puri, K. Ayukawa, S. Kanegasaki, C. Hogaboam, K. Wejksza, C. Lee-Chang (2013)Inhibition of Lung Metastasis by Chemokine CCL17-mediated In Vivo Silencing of Genes in CCR4+ Tregs
Journal of Immunotherapy, 36
Weizhu Zhu, Wenyi Qin, U. Atasoy, E. Sauter (2009)Circulating microRNAs in breast cancer and healthy subjects
BMC Research Notes, 2
Shuiliang Wang, Jingcao Huang, Jingcao Huang, H. Lyu, Choon-Kee Lee, Choon-Kee Lee, Jieqiong Tan, Jinhan Wang, Bolin Liu (2013)Functional cooperation of miR-125a, miR-125b, and miR-205 in entinostat-induced downregulation of erbB2/erbB3 and apoptosis in breast cancer cells
Cell Death & Disease, 4
Xin Sun, S. Qin, C. Fan, Chongwen Xu, N. Du, H. Ren (2013)Let-7: a regulator of the ERα signaling pathway in human breast tumors and breast cancer stem cells.
Oncology reports, 29 5
Yan Wang, J. Gu, J. Roth, M. Hildebrandt, S. Lippman, Y. Ye, J. Minna, Xifeng Wu (2013)Pathway-based serum microRNA profiling and survival in patients with advanced stage non-small cell lung cancer.
Cancer research, 73 15
Rounak Nassirpour, P. Mehta, S. Baxi, M. Yin (2013)miR-221 Promotes Tumorigenesis in Human Triple Negative Breast Cancer Cells
PLoS ONE, 8
Ju-Hee Lee, Ji-Hyun Yeon, Hanna Kim, Whijae Roh, Jeiwook Chae, Han-Oh Park, Dong-Myung Kim (2012)The Natural Anticancer Agent Plumbagin Induces Potent Cytotoxicity in MCF-7 Human Breast Cancer Cells by Inhibiting a PI-5 Kinase for ROS Generation
PLoS ONE, 7
C. Creighton, J. Kurie, D. DuncanCancer Management and Research Dovepress the Role of Epithelial–mesenchymal Transition Programming in Invasion and Metastasis: a Clinical Perspective
Sanchita Roy, Yingjie Yu, S. Padhye, F. Sarkar, A. Majumdar (2013)Difluorinated-Curcumin (CDF) Restores PTEN Expression in Colon Cancer Cells by Down-Regulating miR-21
PLoS ONE, 8
S. Melo, M. Esteller (2011)Dysregulation of microRNAs in cancer: Playing with fire
FEBS Letters, 585
Guoqing Zhao, Jun Guo, Dong Li, Cheng-You Jia, Wanzhong Yin, R. Sun, Zhongwei Lv, Xianling Cong (2013)MicroRNA-34a suppresses cell proliferation by targeting LMTK3 in human breast cancer mcf-7 cell line.
DNA and cell biology, 32 12
Jiemin Ma, A. Jemal (2013)Breast Cancer Statistics
T. Manavalan, Y. Teng, L. Litchfield, Penn Muluhngwi, N. Al-Rayyan, C. Klinge (2013)Reduced Expression of miR-200 Family Members Contributes to Antiestrogen Resistance in LY2 Human Breast Cancer Cells
PLoS ONE, 8
Shadan Ali, Husain Saleh, S. Sethi, F. Sarkar, Philip Philip (2012)MicroRNA profiling of diagnostic needle aspirates from patients with pancreatic cancer
British Journal of Cancer, 107
[Breast cancer is a leading cause of cancer-associated death in women worldwide. The therapy usually involves mastectomy or lumpectomy, followed by chemotherapy and/or radiation therapy in addition to hormonal therapy when indicated. While the area of research on the identification and potential use of microRNAs (miRNAs) as either a diagnostic, prognostic, or predictive biomarker is still in its early stages, there is increasing evidence that miRNAs are involved in tumor progression, chemoresistance, and survival. The miRNAs have enormous prospective in clinical research since they are detected in the serum, plasma, fresh tissues, and formalin-fixed paraffin-embedded tissue samples. Hence, it may be possible to develop novel therapeutic regimens of specific miRNAs as targets to prevent or treat breast cancer (BC). The miRNA expression profiling is now used extensively by many investigators to demonstrate specific miRNA signatures in both the body fluids and in the tumor tissue, indicating that miRNAs may likely be useful as diagnostic and prognostic tools in all cancers including BC. Numerous investigators, including our laboratory, have used strategies to deregulate miRNAs with either anti- and pre-miRNA molecular drugs or even natural compounds to prevent or control tumor progression, which will be discussed in this chapter. Moreover, the role of several natural and synthetic compounds as anticancer agents will also be discussed in this chapter. Finally, the role of several miRNAs as targets will be discussed especially because miRNA-based therapies are currently being exploited for cancer therapy.]
Published: Sep 6, 2014
Keywords: Breast cancer; Serum; FFPE; miR-21; miR-125; miR-34a; miR-200; miR-155; miR-10b; Plumbagin; Garcinol; Curcumin
Access the full text.
Sign up today, get DeepDyve free for 14 days.